Teladoc Health
TDOC
828 hedge funds and large institutions have $21.3B invested in Teladoc Health in 2021 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 335 increasing their positions, 288 reducing their positions, and 141 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 288
3.15% more ownership
Funds ownership: 79.7% → 82.84% (+3.1%)
4% less capital invested
Capital invested by funds: $22.1B → $21.3B (-$787M)
7% less funds holding
Funds holding: 889 → 828 (-61)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
38% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 141
42% less call options, than puts
Call options by funds: $1.86B | Put options by funds: $3.18B
Top Buyers
Top Sellers
TDOC Hedge Fund Activity: Q2 2021 in Review
828 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q2 2021, worth a combined $21.3B — down 3.6% from $22.1B a quarter earlier.
Sellers outnumbered buyers: 141 funds closed out of TDOC and 87 opened new positions — a net loss of 54 holders — while 288 trimmed existing stakes and 335 added.
The largest buyer was ARK Investment Management, adding an estimated $258M. The largest seller was General Catalyst Group Management, cutting an estimated $217M.
- 828 institutional investors held Teladoc Health (TDOC) as of Q2 2021, down from 889 in Q1 2021.
- Funds reported $21.3B of Teladoc Health stock for Q2 2021, down 3.6% quarter-over-quarter.
- 87 funds opened new Teladoc Health positions in Q2 2021 and 141 closed out, a net change of -54 holders.
- The largest Teladoc Health buyer in Q2 2021 was ARK Investment Management, an estimated $258M added.
- The largest Teladoc Health seller in Q2 2021 was General Catalyst Group Management, an estimated $217M sold.
Based on aggregated 13F filings for Q2 2021.